Polar Capital Holdings PLC Y M Abs Therapeutics, Inc. Transaction History

Polar Capital Holdings PLC

$16 Billion
Q1 2024

A detailed history of Polar Capital Holdings PLC transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Polar Capital Holdings PLC holds 1,831,000 shares of YMAB stock, worth $22.1 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

1,831,000

Previous 2,056,872 10.98%

Holding current value

$22.1 Million

Previous $14 Million 112.25%

% of portfolio

0.19%

Previous 0.1%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$6.57 - $18.69 $1.48 Million - $4.22 Million	-225,872 Reduced 10.98%	1,831,000 $29.8 Million
Q4 2023 Feb 14, 2024	SELL	$4.88 - $7.42 $226,558 - $344,480	-46,426 Reduced 2.21%	2,056,872 $14 Million
Q2 2023 Dec 13, 2023	BUY	$5.68 - $10.34 $632,575 - $1.15 Million	111,369 Added 5.59%	2,103,298 $14.3 Million
Q2 2023 Aug 14, 2023	BUY	$5.68 - $10.34 $632,575 - $1.15 Million	111,369 Added 5.59%	2,103,298 $14.3 Million
Q1 2023 Dec 13, 2023	SELL	$2.83 - $5.11 $315,174 - $569,095	-111,369 Reduced 5.29%	1,991,929 $9.98 Million

Q4 2022 Feb 14, 2023	SELL	$3.0 - $15.17 $1.62 Million - $8.19 Million	-539,617 Reduced 21.32%	1,991,929 $9.72 Million
Q3 2022 Nov 14, 2022	SELL	$13.96 - $19.67 $5.88 Million - $8.28 Million	-421,125 Reduced 14.26%	2,531,546 $36.5 Million
Q2 2022 Aug 15, 2022	BUY	$8.22 - $15.13 $616,500 - $1.13 Million	75,000 Added 2.61%	2,952,671 $44.7 Million
Q1 2022 May 16, 2022	BUY	$6.55 - $17.42 $9.83 Million - $26.1 Million	1,500,000 Added 108.88%	2,877,671 $34.2 Million
Q4 2021 Feb 14, 2022	BUY	$15.51 - $29.31 $3.45 Million - $6.53 Million	222,710 Added 19.28%	1,377,671 $22.3 Million
Q3 2021 Nov 15, 2021	BUY	$27.47 - $37.31 $15.6 Million - $21.2 Million	569,040 Added 97.12%	1,154,961 $33 Million
Q2 2021 Aug 16, 2021	BUY	$25.45 - $37.64 $14.7 Million - $21.8 Million	577,892 Added 7197.56%	585,921 $19.8 Million
Q1 2021 May 17, 2021	SELL	$29.16 - $51.96 $14.6 Million - $26 Million	-499,604 Reduced 98.42%	8,029 $243,000
Q4 2020 Feb 16, 2021	BUY	$37.86 - $54.26 $19.2 Million - $27.5 Million	507,633 New	507,633 $25.1 Million

Others Institutions Holding YMAB

# of Institutions

Shares Held

22.4M

Call Options Held

37.4K

Put Options Held

48.2K

View Full List

About Y-mAbs Therapeutics, Inc.

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $528M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

More about YMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.

Account

Polar Capital Holdings PLC Y M Abs Therapeutics, Inc. Transaction History